Pharmaceuticals - Fundamentals of Industrial Chemistry: Pharmaceuticals, Polymers, and Business - page 182

25. DJ Carini, JJV Duncia, PCB Wong. U.S. Pat. No. 5,138,069. 1992.
26. W Cabri, R DiFabio. From Bench toMarket . Oxford University Press; 2000:125.
27. W

Cabri, R DiFabio. From Bench to Market . Oxford University Press;

2000:127 - 142.
28. B Singh, FC Schaefer. U.S. Pat. No. 4,374,987. 1983.
29. John McMurry. Organic Chemistry . 7th ed. Brooks/Cole, Belmont, CA;

2008:303.
30. Lester Friedman, John Miller. Science 1971; 172:1044 - 1046.
31. Editorial. Am. J. Respir. Crit. Care Med. 2006; 174:965 - 974.
32. Timothy Barberich, James Young. U.S. Pat. No. 5,362,755. 1994.
33. Rick Ng. Drugs From Discovery to Approval . 2nd ed. New York:

Wiley-Blackwell; 2009:339.
34. L Nguyen, H He, C Pham-Huy. International Journal of Biomedical Science
2006; 2:85 - 100.
35. Rick Mullin. Chemical and Engineering News 2010; 88(49):14 - 21.
36. Fulvio Gualtieri. New Trends in Synthetic Medicinal Chemistry. New York:
Wiley-VCH; 2000:98.
37. Stephen Ritter. Chemical and Engineering News 2013; 91(10):34.
38. Jie-Jack Li, Douglas Johnson, Drago Sliskovic, Bruce Roth. ContemporaryDrug
Synthesis . New York: Wiley; 2004:22 - 23.
39. Rick Mullin. Chemical and Engineering News 2010; 88(49):14 - 21.
40. Jie-Jack Li, Douglas Johnson, Drago Sliskovic, Bruce Roth. ContemporaryDrug
Synthesis . New York: Wiley; 2004:25.
41. Fulvio Gualtieri. New Trends in Synthetic Medicinal Chemistry. New York:
Wiley-VCH; 2000:205.
42. Fulvio Gualtieri. New Trends in Synthetic Medicinal Chemistry. New York:
Wiley-VCH; 2000:211.
43. Douglas Johnson, Jie-Jack Li. The Art of Drug Synthesis. New York: Wiley;
2007:210 - 211.
44. L Nguyen, H He, C Pham-Huy. International Journal of Biomedical Science
2006; 2:85 - 100.
45. S Mohan, et al. International Journal of Pharmaceutical Sciences and Nanotech-
nology 2009; 1(4):309 - 316.
46. John LaMattina. Drug Truths. New York: John Wiley & Sons; 2009:113.